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ABSTRACT  The thyroid hormone is involved in cardiac adaptation to physiological and 
pathological stimuli. Although short-term hyperthyroidism enhances cardiac performance, 
longstanding hyperthyroidism can cause impairment of the contractility by pathological Ca2+ 
handling. Because the thyroid hormone affects cardiovascular hemodynamics by decreasing 
systemic arterial resistance and increasing circulating blood volume, it is important to 
accurately analyze left ventricular (LV) mechanics by using an index that is independent of 
ventricular loading conditions. Therefore, we adopted the end-systolic elastance (Ees), which 
is obtained by the linear regression of the end-systolic pressure-volume relationships. This 
reflects sensitive changes in the contractile state in a manner independent of both preload 
and afterload, providing an index of LV contractility. To better understand the hypertrophy 
caused by hyperthyroidism, we normalized the Ees according to LV weight for different sized 
heart. Hyperthyroidism was induced by a daily intraperitoneal injection of triiodothyronine (T3) 
at a dose of 2,000 mg/kg body weight. Mice were divided into three groups: the synchronous 
control group, the T3 administration for one-week group (T3-short), and the T3 administration 
for eight-week group (T3-long). We investigated global LV mechanics, the expression of Na+/
Ca2+ exchanger (NCX), the sarco/endoplasmic reticulum Ca2+-ATPase (SERCA), and the 
Ca2+ handling of isolated cardiomyocytes in each group. Ees values in the control and T3-
short were similar, and those in T3-long were significantly smaller than the control (256 ± 
60, 249 ± 70 and 154 ± 57 mmHg･ml-1･gLV-1, respectively). The values of arterial elastance 
in both T3-short and T3-long, which represent afterload, were significantly smaller than the 
control. NCX expression was decreased in T3-short and declined in a time-dependent manner 
in T3-long. On the other hand, SERCA expression was rapidly elevated in T3-short and 
remained high in T3-long. These changes may be beneficial for cardiomyocytes in terms of 
O2 consumption for excitation-contraction coupling. In isolated cardiomyocyte experiments, 
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INTRODUCTION
   The thyroid hormone affects cardiac function by 
regulating many factors in the myocardium, such 
as calcium handling１）, shape and geometory２）, 
and electorophysiological function３，４）. Clinically, 
hyperthyroidism results in enhanced cardiac 
contractility and relaxation subsequently causes 
congestive heart failure. One possible mechanism 
behind the transition of the initial adaptive response 
to decompensation can be tachycardia, which 
increases myocardial intracellular calcium. It has 
been reported that suppression of the heart rate did 
not completely prevent myocardial hypertrophy 
and subsequent deterioration of the cardiac 
function５）. Therefore, there must be other reasons 
why longstanding hyperthyroidism causes heart 
failure.
   Calcium is a significant factor not only in the 
regulation of excitation-contraction coupling but 
also in the development of cardiac hypertrophy 
and heart failure６）. One critical calcium-related 
molecular mechanism of cardiac hypertrophy 
is calcineurin signaling, which regulates the 
translocation of the transcription factor nuclear 
factor of activated T-lymphocyte-3 to the nucleus 
through calcium-dependent dephosphorylation７）. 
The calmodulin-dependent protein kinase also plays 
an important role in regulating cardiac hypertrophy 
in a calcium-dependent manner８）.
   In myocardium, calcium is handled by various 
calcium transport proteins in the sarcoplasmic 
reticulum and plasma membrane, such as L-type 
calcium channel (LTCC), Na+/Ca2+ exchanger 
(NCX), ryanodine receptor 2 (RYR-2), and sarco/
endoplasmic reticulum Ca2+-ATPase (SERCA). 
These Ca2+ transporters play a pivotal role in 
excitation-contraction coupling (E-C coupling), and 
there are two major Ca2+ handling routes. One is 
the route recirculating Ca2+ intracellularly via the 
sarcoplasmic reticulum (SR), and the other is the 
route entering Ca2+ via LTCC and extruding Ca2+ 
by NCX. Since these intracelluler (internal) and 
transsarcolemmal (external) handlings have different 
molecular Ca2+ ATPase stoichiometries, regulation of 
Ca2+ transporters may be very important to maintain 
cardiac function. Although an antithetical regulation 
of NCX and SERCA in short-term hyperthyroidism 
has been reported１）, calcium dynamics in the thyroid 
hormone-induced failing of the myocardium have 
not been investigated.
   Cardiovascular  hemodynamics  are  a lso 
significantly affected by the thyroid hormone. Direct 
effects on vascular smooth muscle cells at arterioles 
decrease systemic arterial resistance９）. The thyroid 
hormone also activates the rennin-angiotensin-
aldosterone system and increases renal sodium 
reabsorption, resulting in an increase in circulating 
blood volume10）. Therefore, it may be insufficient 
to characterize the effects of the thyroid hormone 
on cardiac pump function with conventional, 
cell shortening of T3-long mice was significantly lower than that of the control mice, but the 
average peak amplitude of Ca2+ transients in T3-long was 79% and not significantly different. In 
conclusion, we evaluated LV contractility by using an Ees index in hyperthyroid mice. Although 
T3 administration shifted the Ca2+ route in excitation-contraction coupling to the O2-saving 
energetics, LV contractility was diminished with long-term T3 administration, showed constancy 
in peak amplitude of the Ca2+ transients, and a decrease in NCX activity.
 doi：10.11482/KMJ-E41（2）41　(Accepted on October 6, 2015)
Key words： Cardiac hypertrophy,  Contractility,  Mice,  Sodium-calcium exchanger,   
Sarcoplasmic reticulum Ca2+ ATPase
43Sasae Y, et al. : LV mechanics and Calcium dynamics in hyperthyroidism
preload- (circulating blood volume), and afterload- 
(systemic arterial resistance) dependent cardiac 
parameters. The end-systolic elastance (Ees), which 
is obtained from the linear regression of the end-
systolic pressure-volume relationships (ESPVRs), 
reflects sensitive changes in the contractile state 
in a manner independent of ventricular loading 
conditions11）. Moreover, the hyperthyroidism causes 
cardiac hypertrophy and changes the heart size. 
When we compare cardiac contractility between 
different sized hearts, Ees must be normalized with 
respect to the heart size because the Ees of a smaller 
heart tends to be greater than that of a larger heart. 
One method of normalizing Ees for different sized 
hearts is dividing ventricular end-systolic volume by 
ventricular wall weight and then dividing ventricular 
end-systolic pressure by this normalized volume11）. 
Using this normalizing method, we succeeded in 
accurately evaluating ventricular mechanics in 
hyperthyroid mice in different cardiac states.
   In this study, we evaluated the left ventricular 
(LV) mechanics using Ees, which is practically 
load-independent and normalized by LV weight 
and corresponding NCX and SERCA expression, 
and the intracellular calcium dynamics of isolated 




   Experiments were performed on male C57/
BL6J mice aged 8-week old (weighing 22-
24 g). Hyperthyroidism was induced by daily 
intraperitoneal injections of T3 (2,000 mg/kg body 
weight). Mice were divided into three groups: the 
synchronous control group, the T3 administration for 
1 week group (T3-short), and the T3 administration 
for 8 weeks group (T3-long). T3 was purchased 
from Sigma (St. Louis, USA). All procedures in 
this study were approved by the Kawasaki Medical 
School Institutional Review Board. 
Surgical preparation
   The part of left ventricular pressure and volume 
study was performed in 15 mice (n = 5 each group). 
Mice were anesthetized with sevoflurane (2-5%) 
and intubated. They were mechanically ventilated 
using a volume-controlled ventilator (SN-480-7 
Shinano) with tidal volume 200 ml and respiratory 
rate 120 breath/min. The diaphragm was opened 
via an abdominal incision and the pericardium 
was dissected to expose the heart. After soaking in 
saline for 30 minutes to hydrate the sensor properly, 
we introduced a 1.2 Fr conductance catheter 
(ADVantageTM 5.0, Scisence Inc.) into LV through 
an apical stab made by the puncture using 27G 
needle to measure the LV volume and pressure. 
The distal electrode of the catheter was positioned 
carefully at the level of the aortic valve and the 
proximal electrode near the apex. A 4-0 suture was 
placed loosely around the inferior vena cava for 
occlusion (IVCO) to decrease the LV preload (end-
diastolic volume).
Experimental protocol and data analysis in LV 
mechanics
   After completion of the surgical preparation, 
steady-state LV pressure and volume signals were 
recorded. Subsequently, the signals during IVCO (～
5 sec) were recorded. Concentration of sevoflurane 
was controlled to keep the heart rate 500 ± 20 
beats/min. The ventilator was stopped during data 
acquisition to avoid respiratory fluctuation of 
cardiac signals.
   The end-systolic pressure-volume relationships 
(ESPVRs) were obtained from the data during 
IVCO in the usual fashion12） and analyzed by linear 
regression to obtain the LV contractility index end-
systolic elastance (Ees). In this study, we tried to 
compare the cardiac contractility among the LVs 
of different sizes because thyroid hormone caused 
LV hypertrophy. Therefore we adopted the method 
of normalizing the Ees (n-Ees) for different sized 
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heart that was to divide LV volume by LV weight 
as reported previously13）. Ejection fraction (EF) 
was calculated as 100･(EDV－ESV)/EDV, where 
EDV and ESV are the end-diastolic and end-
systolic LV volume, respectively. To evaluate the 
LV afterload, we obtained arterial elastance (Ea) 
by calculating the ratio of end-systolic pressure 
to stroke volume (SV)14）. It has been recognized 
that systemic vascular resistance (SVR) decreases 
in hyperthyroidism. SVR is obtained by dividing 
the mean aortic pressure by the cardiac output; 
therefore, the unit of SVR is mmHg/min/mL-1. Ea 
is synonymous with SVR, and its unit is mmHg/
mL-1. Inotropic and lusitropic properties were also 
evaluated by determining maximum (+max dP/dt) 
and minimum (-max dP/dt) rate of pressure change 
and the time constant of pressure decay during 
relaxation as indexed by the logistic time constant 
(τL)
15）. For calculation of τL, we analyzed the 
time constant of isovolumic relaxation from the 
time of peak -dP/dt to the time when LVP fell to 5 
mmHg above the EDP using a least-squares method 
performed in Kaleida Graph (Synergy software).
Immunoblotting
   Hearts were collected from mice and snap frozen 
in liquid nitrogen. Minced tissues were homogenized 
u s i n g  P o l y t r o n  h o m o g e n i z e r  ( P T1600E , 
Kinematica) or MicroSmash homogenizer (MS-
100R, Tomy, Japan) in one of the following lysis 
buffer: 10mM Tris-HCl; pH7.5, 150mM NaCl, 
0.5mM EDTA, 10mM NaF, and 0.5% Triton X-100, 
M-PER Mammalian Protein Extraction Reagent 
(Thermo Scientific), or cytoplasmic extraction 
buffer from Subcellular Protein Fractionation Kit 
(Thermo Scientific) in the presence of protease 
and phosphatase inhibitor cocktail (Thermo 
Scientific or Roche). Lysates were centrifuged at 
14,000 g for 10 min and supernatants were used 
for immunoblot analysis. After quantifying total 
protein concentrations by bicinchoninic acid (BCA) 
method, equal amount of proteins were loaded 
on 4%-15% SDS-PAGE gradient gels (Bio Rad), 
separated, and transferred onto polyvinylidene 
difluoride (PVDF) membranes (GE Healthcare). 
After blocking the membranes with 3% BSA in 
TBS-T, they were probed with primary antibodies 
for NCX (1:3000 dilution, anti-NCX antibody was 
a kind gift from Dr. Yuki Katanosaka, Okayama 
University, Japan16） or SERCA (1:1000 dilution, 
MA3-919, Thermo Scientific). The membranes were 
then probed with secondary horseradish peroxidase 
(HRP)-conjugated IgG (GE Healthcare), and 
finally visualized by enhanced chemiluminescence 
(Western Lightning ECL-Pro, PerkinElmer) using 
LAS4000mini luminescent image analyzer (Fuji 
Film). Densitometry analysis was performed using 
Image J software.
qPCR
   Hearts were collected from mice, cut into small 
pieces, and immediately immersed in RNAlater 
RNA Stabilization Reagent (Qiagen). The stabilized 
tissues were homogenized with MicroSmash 
homogenizer (MS-100R, Tomy, Japan), and total 
RNA was isolated using RNeasy Fibrous Tissue 
Mini Kit (Qiagen). After assessing RNA yield and 
quality by NanoDrop spectrophotometer (ND-
1000, Thermo Scientific), RNA samples were 
reverse-transcribed with PrimeScrip RT Master 
Mix (Takara), and quantitative PCR was performed 
with TaqMan Fast Advanced Master Mix in a 
StepOnePlus real time PCR system (Applied 
Biosystems) for thyroid hormone receptor α 
(Thra, Mm00579691_m1, Applied Biosystems). 
Quantification of Thra mRNA was carried out with 
Rn18S (Mm03928990_g1, Applied Biosystems) as 
the reference gene using the ΔΔCT method.
Isolation of adult mouse ventricular myocytes
   Single cardiomyocytes were enzymatically 
isolated from mice in a similar method to previous 
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studies17，18）. Firstly, hearts were rapidly removed 
from the mice anesthetized with an overdose of 300 
mg/kg pentobarbital, i.p., and then Langendorff-
perfused for 3-4 min at 37 ℃ using cell isolation 
buffer (CIB: 130 mM NaCl, 5.4 mM KCl, 0.5 mM 
MgCl2, 0.33 mM NaH2PO4, 22 mM glucose, 50 
nM/ml bovine insulin (Sigma) and 25 mM HEPES-
NaOH (pH 7.4).) supplemented with 0.4 mM EGTA 
(EGTA-CIB). Then, the perfusate was switched 
to enzyme solution (CIB containing with 1 mg/
ml collagenase (Worthington Biochemical), 0.06 
mg/ml trypsin (Sigma) and 0.06 mg/ml protease 
(Sigma)) supplemented with 0.3 mM CaCl2. After 
6-9 min, the left ventricular tissue was excised 
from the digested heart, and it was cut into several 
pieces and further digested in 10 ml fresh enzyme 
solution supplement with 0.7 mM CaCl2 and 2 
mg/ml BSA (Sigma) for 15-20 min at 37 ℃. The 
cell suspension was centrifuged at 14 × g for 5 
min and the cell pellet was resuspended in CIB 
supplemented with 1.2 mM CaCl2 and 2 mg/
ml BSA, and then incubated at 37 ℃ for 10 min. 
Following centrifugation, finally, the cell pellet was 
resuspended in standard Tyrode’s solution (140 mM 
NaCl, 5.4 mM KCl, 1.8 mM CaCl2, 0.5 mM MgCl2, 
0.33 mM NaH2PO4, 11 mM glucose, 2 mg/ml BSA 
and 5 mM HEPES-NaOH (pH 7.4)). 
Measurements of cell shortenings and intracellular 
Ca2+ transients in cardiomyocytes
   Cell shortenings and intracellular Ca2+ transients 
induced by electronic stimulations were measured 
as previously described18，19）. Isolated cells were 
electrically stimulated at 1 Hz in standard Tyrode’s 
solution using a two-platinum electrode insert 
connected to a bipolar stimulator (SEN-3301, Nihon 
Kohden). They were examined using an inverted 
microscope (IX71, Olympus) with a 20 × water 
immersion objective lens (UApo N340, Olympus). 
Images were acquired using a High-performance 
EvolveTM EMCCD camera (Photometrics) and 
obtained images were analyzed using MetaMorph 
software (Molecular Devices).
Measurements of intracellular Ca2+
   Indo-1  AM (Doj indo)  was  used  for  the 
measurements of Ca 2+ transients evoked by 
electronic stimulation at 1 Hz. Isolated cells were 
loaded with 10 μM indo-1 AM for 10 min at 
37 ℃. Cells loaded with Indo-1 AM were examined 
in standard Tyrode’s solution using the same 
experimental apparatus as the measurement of cell 
shortenings. Cells were excited with 340 nm with 
emissions of 405 and 485 nm. Ca2+ transients were 
measured as the difference of the 405/480 ratio from 
basal levels. To evaluate the decay speed after peak 
Ca2+ transients, the time constant was calculated 
by fitting a mono-exponential curve to the decay 
of the normalized Ca2+ transient (from 90% to 10% 
amplitude). Fura-2 AM (Dojindo) was used as an 
intracellular indicator of Ca2+ for the measurement 
of NCX activity and SR Ca2+ content. Isolated cells 
were loaded with 5 μM Fura-2 AM for 30 min at 
37 ℃. Cells were studied using an inverted IX71 
microscope (Olympus) with a UApo 20×/0.75 
objective lens (Olympus). Cells were excited at 
340 and 380 nm using a Lambda DG-4 Ultra High 
Speed Wavelength Switcher (Sutter Instruments) 
and the fluorescent emissions (F340 and F380) 
were recorded with ORCA-Flash 2.8 (Hamamatsu 
Photonics) analyzed by a ratiometric fluorescence 
method using MetaFluor software (Molecular 
Devices) as previously described20）. The signal was 
expressed as the ratio (F340/F380) of the emissions 
at those excitation wavelengths. 
Measurements SR Ca2+ contents
   SR Ca2+ content was measured as Ca2+ increase 
induced by caffeine. After cells loaded with Fura-2 
were electrically stimulated until Ca2+ transients 
reached steady-state, 10 mM caffeine was rapidly 
applied. Peak amplitude of a caffeine-induced Ca2+ 
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transient was taken as an index of SR Ca2+ content.
Measurements of NCX activity
   NCX activity in cells was measured as intracellular 
Na+-dependent Ca2+ uptake by a modification of 
previously describes16）. Following Fura-2 loading, 
cells were loaded with Na+ by incubating them at 
37 ℃ for 15 min in normal BSS (10mM Hepes/Tris 
(pH7.4), 146 mM NaCl, 4 mM KCl, 2 mM MgCl2, 
0.1 mM Ca2Cl, 10 mM glucose, and 0.1% BSA) 
containing 1 μM ouabain, 1 μM thapsigargin and 
1 μM monensin. After Na+ loading, the cells were 
washed in normal BSS containing 1 μM ouabain, 
1 μM thapsigargin, 5 μM nifedipine. Ca2+ uptake 
was performed by perfusing the cells with Na+-free 
(choline chloride+ containing) BSS containing 1 
μM ouabain, 1 μM thapsigargin, 5 μM nifedipine. 
NCX activity was evaluated by calculating the slope 
of the line obtained by linear regression analysis of 
the relationship between Fura-2 ratio and time for 
first 20 s after medium switching.
Immunofluorescence microscopy
   Excised hearts were immediately embedded in 
OCT compound (Tissue-Tek) and were frozen. 
Frozen heart blocks were sectioned to a thickness of 
5 μm. The sections were washed with phosphate-
buffered saline (PBS) and permeabilized with 
PBS containing 0.1% Triton X-100 for 5 min. 
The sections were then immersed in Block-One 
(Nacalai Tesque) for 30 min to block non-specific 
binding, and were incubated with the primary 
antibody against NCX1 for 1h at 4 ℃. The sections 
were washed with PBS conaining 0.1% Tween 
20 (PBS-T) and then they were exposed to Alexa 
Fluor 488-conjugated anti-rabbit IgG antibody 
(Life Technologies) in PBS-T for 15 min. After the 
sections were washed with PBS-T, nuclei stained 
with DAPI (Life Technologies) in PBS-T for 5 min 
at 4 ℃. The sections were washed with PBS-T 
again, and they were mounted with Dako fluorescent 
mounting medium (DAKO). The fluorescently 
stained sections were observed under a confocal 
laser scanning microscope (FV1000, Olympus) with 
a UPlanApo ×60/1.35 oil immersion objective lens 
(Olympus).
Statistics
   Results are presented as mean ± SEM but 
presented as mean ± SD in variables of LV 
mechanics in Table. They were analyzed by one-
way analysis of variance (ANOVA) followed by 
Dunnett’s test for comparison against a control 




   Representative steady-state tracings of LV 
pressure, pressure-volume loops and variables of 
cardiac mechanics are shown in Fig. 1 and table. 
Both EDV and LV weight significantly increased in 
T3-long compared with control. n-EDV, the quotient 
of EDV and LV weight, significantly increased in 
T3-short and T3-long, indicating that the lumen-
to-wall ratio at end-diastole was increased by T3 
administration. Peak LV pressure in T3-long was 
significantly lower compared with that of control. 
There was no significant difference in cardiac 
contractility Ees between the control and T3-
short. In T3-long, there was a rightward shift of the 
ESPVR (decreased contractility; Fig. 1B, D, and F), 
and Ees decreased significantly. 
   The values of Ea in T3-short and T3-long were 
significantly smaller than the control, indicating that 
the LV afterload was decreased by T3. Greater EF in 
T3-short than that in the control can be explained by 
similar contractility and a lower LV afterload in T3-
short. On the other hand, diminished contractility 
resulted in lower EF despite a decreased LV 
afterload in T3-long. Using Ees, which is a preload 
and afterload independent index of ventricular 
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Fig. 1. Representative set of left ventricular pressure curves (left) and pressure-volume loops (right) during inferior vena cava 
occlusion of control (upper), T3-short (middle) and T3-long (lower). Broken lines show the end-systolic pressure-volume 
relationship and their slopes are Ees representing ventricular contractility (B, D and F). Sasae Y., et al. Figure 1
Table. Variables of LV mechanics in each group
Variable Control （n = 5） T3-short （n = 5） T3-long （n = 5）
EDV （x10－3 ml） 69.6 ± 13.5 93.0 ± 22.7 123 ± 32.9*
Peak LV Pressure （mmHg） 105 ± 8.4 99 ± 7.3 84 ± 7.3*
LV weight （x10－3 g） 77.8 ± 8.93 84.6 ± 7.40 107 ± 11.6*
n-EDV （ml · gLV－1） 0.913 ± 0.245 1.11 ± 0.304* 1.14 ± 0.212*
Ees （mmHg · ml－1· gLV－1） 256 ± 60 249 ± 70 154 ± 57*
EF （%） 51.8 ± 8.35 55.8 ± 10.5* 38.8 ± 12.4*
Ea （mmHg · ml－1） 2.52 ± 0.55 1.70 ± 0.31* 1.54 ± 0.35*
+max dP/dt （mmHg · s－1） 7238 ± 663 7683 ± 371 7825 ± 428
－max dP/dt （mmHg · s－1） 6910 ± 732 7526 ± 402 7665 ± 440
τL （ms） 9.88 ± 1.70 9.18 ± 1.18 7.68 ± 1.08* 
Each value indicates mean ± SD. Ees, end-systolic elastance; EDV, end-diastolic volume; LV 
pressure, left ventricular pressure; n-EDV, EDV normalized for 1 g LV weight; EF, ejection 
fraction; Ea, arterial elastance; +max dP/dt, maximum positive value of time derivative of LV 
pressure; -max dP/dt, maximum negative value of time derivative of LV pressure; τL, time 
constant of isovolumic relaxation pressure segment after -max dP/dt. Statistically significant 
difference at *: p<0.05 compared with control.
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Fig. 2. (A) Whole (cytoplasmic) protein extracts were obtained from adult mouse hearts (control, T3-short, and T3-long), and 
analyzed by western blotting for NCX (B) and SERCA (C). * P <0.05, ** P <0.01 vs. control group by one-way analysis of 
variance followed by Dunnett's post hoc test. Data were normalized to the control level which was set at 1 and expressed as mean 
plus SEM. n = 4, 4, and 6 mice for control, T3-short, and T3-long, respectively for NCX. n = 6, 5, and 4 mice for control, T3-
short, and T3-long, respectively for SERCA. Sasae Y., et al. Figure 2
contractility, we could evaluate cardiac performance 
per se under different conditions of arterial 
resistance and circulating blood volume. As for 
the pressure-derived indices, τL in T3-long was 
significantly smaller than the control, and there 
were no significant differences in either +max dP/dt 
or -max dP/dt (Table, Fig. 1A, C, and E).
Immunoblotting
   As shown in Fig. 2, NCX1 protein expression 
decreased after T3 administration for one week 
(T3-short), and it further declined in a time-
dependent manner with long-term administration 
(T3-long). On the other hand, the expression level 
of SERCA2 rapidly elevated with one week of T3 
administration, and it remained high with the long-
term administration.
Ca2+ measurements in isolated cardiomyocytes
   To understand the effects of T3 on cardiomyocytes, 
we analyzed cell morphology and shortening in 
cardiomyocytes that were isolated from hearts in the 
control, T3-short and T3-long mice. Cells isolated 
from T3-short mice were rod-shaped, as were those 
of the control, although the projected area was 
increased (Fig. 3A and C). Cell shortening of T3-
short was almost the same level as that of the control 
(Fig. 3B). By contrast, the cells in T3-long mice 
showed an irregular structure with a significantly 
increased projected area (Fig. 3A and C). Cell 
shortening of T3-long mice showed significantly 
lower than that of control (Fig. 3B). Thus, the mice 
treated with T3 for a long time showed abnormal 
morphology and impaired contractility at the single 
cell level.
   We further investigated how T3 administration 
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Fig. 3. Effects of T3 on the morphology and function of cardiomyocytes. 
(A) Representative images of cardiomyocytes isolated from control, T3-short and T3-long mice. 
(B) Cell shortenings of isolated cardiomyocytes electrically stimulated at 1Hz. Control n = 28, T3-short n = 35, T3-long n = 18. 
(C) Projected areas of isolated cardiomyocytes. 
(D) Averaged traces of Ca2+ transients in isolated cardiomyocytes electrically stimulated at 1 Hz. 
(E) Peak amplitude of electrically evoked Ca2+ transients. 
(F) Time to peak of electrically evoked Ca2+ transients. 
(G) Decay time constant of electrically evoked Ca2+ transients. 
(C)-(G) Control n = 21, T3-short n = 21, T3-long n = 15. 
(H) SR Ca2+ content measured as peak amplitude of caffeine-induced Ca2+ transients. Control n = 12, T3-short n = 25, T3-long n = 9. 
(I) NCX activities in isolated cardiomyocytes. Control n = 16, T3-short n = 25, T3-long n = 10. Values are expressed as means ± 
SEM. n = number of cells.
Sasae Y., et al. Figure 3
altered Ca2+ handling in cardiomyocytes. In T3-
short mice, Ca2+ transients evoked by electrical 
stimulations showed no noticeable changes 
compared with those in the control (Fig. 3D). 
Although SR Ca2+ content and NCX activity in T3-
short mice were slightly smaller than those in the 
control mice, there were no significant differences 
(Fig. 3H and I). In T3-long, the averaged peak 
amplitude of the electrically-evoked Ca2+ transients 
and SR Ca2+ content were 79% and 82% of control 
values, respectively (Fig. 3E and H). Surprisingly, 
despite an obvious reduction in NCX activity (Fig. 
3I), the decay time constant of the Ca2+ transient in 
T3-long mice was significantly shortened (Fig. 3G). 
These results suggest that enhanced SERCA activity 
is responsible for the increased rate of Ca2+ removal 
from the cytosol in T3-long mice. 
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Fig. 4. The changes in the localization of NCX in Control, T3-short and T3-long mice. Double staining with anti-NCX1 antibody 
(green) and DAPI (blue).
Sasae Y., et al. Figure 5
Fig. 5. Total RNA was obtained from adult mouse hearts 
(control, T3-short and T3-long), reverse-transcribed, and 
analyzed by quantitative real time PCR for thyroid hormone 
receptor α. ** P <0.01 vs. control group by one-way 
analysis of variance followed by Dunnett's post hoc test. Data 
were normalized to the control level which was set at 1 and 
expressed as mean plus SEM. n = 6, 3, and 5 mice for control, 
T3-short and T3-long, respectively.
Fluorescent immunostaining
   Because NCX is mainly localized in T-tubule 
membranes in the control hearts, immunofluorescent 
signals of the NCX and ordered patterns appeared 
(Fig. 4). In mice treated with T3 for a short time, 
NCX was normally expressed in the control mice. 
In contrast, the density and regularity of NCX 
staining were greatly defective in mice treated with 
T3 for a long time. This suggests that NCX activity 
significantly decreased. 
qPCR
   As shown in Fig. 5, mRNA expression of the 
thyroid hormone receptor α decreased to about 
40% of the control level after one week of T3 
administration (T3-short), and it recovered to about 
50% with long-term administration (T3-long).
DISCUSSION
   We are the first to succeed in evaluating LV 
contractility using the practically load-independent 
Ees index in hyperthyroidism at different stages 
in in vivo mice. According to the time-varying 
elastance model, the elastance of the LV wall 
increases from an end-diastolic compliant level to 
end-systolic stiff level (Fig. 6). The increments in 
elastance can be expressed as a thickened spring 
during contraction, and the largest value of the 
ESPVR provides the contractility of LV (Fig. 6)21）. 
Although this index is widely used to evaluate 
global ventricular contractility in acute experiments, 
precise application to the chronic experiment, 
such as hypertrophy caused by mechanical load 
or drugs, has not been investigated. In the present 
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Fig. 6. Interpretations of LV hypertrophy by time-varying elastance model. 
(A) Time-varying P-V relation changes its slope as a function of time. Ees (end-systolic elastance) represents cardiac contractility. 
Schematic left ventricle (LV) includes the spring that increases its elastance during contraction. The elastance of LV wall 
increases from the end-diastolic complaint level to the end-systolic stiff level. 
(B) Schematic LV in control, T3-short, and T3-long (upper), and corresponding conceptual springs in end-systole and end-
diastole (lower). The thickness of spring shows its elastance. In T3-short, an additional spring (shown in green) indicates added 
myocardial tissue by hypertrophic response. The same thickness of spring at end-systole indicates the same contractility per 
unit myocardium. Although the length of spring increases further in T3-long (shown in red), the thickness of spring decreases 
indicating that the LV is failing. 
study, LV weight increased, but Ees was almost 
the same as the control in T3-short, indicating that 
T3 caused LV hypertrophy by adding myocardial 
tissues that had similar contractile properties to 
the control heart (Fig. 6). On the other hand, Ees 
in T3-long was significantly lower compared with 
the control, indicating that LV contractility per unit 
LV weight was diminished (Fig. 6). As a result, the 
hearts in T3-long were failing and showed lower 
EF compared with the control despite a significant 
increase in LV weight and lower afterload (Ea). 
If we evaluate the hearts in this model using EF, 
which is clinically popular but load-dependent, LV 
in T3-short showed better cardiac function than the 
control.
   Previously, there were two studies that have 
reported the effects of hyperthyroidism on the heart 
using Ees or Emax (an index of LV contractility; 
a synonym of Ees) in cross-circulated dog and 
rabbit hearts22，23）. Suga H. et al. showed that LV 
contractility indexed by Emax was increased with 
an increase of heart rate in dog hyperthyroidism22）. 
They also obtained LV oxygen consumption by 
the measurements of coronary flow and coronary 
arteriovenous O2 content difference. Using the 
framework of pressure-volume area and O2 
consumption (Vo2) relation analysis, which separates 
Vo2 for excitation-contraction (E-C) coupling to 
from total Vo2 of beating heart
11）, they reported 
that hyperthyroidism did not increase Vo2 for E-C 
coupling and basal metabolism compared with that 
of euthyroid dog despite LV contractility increasing 
significantly. They concluded that the O2 saving 
effect for E-C coupling in hyperthyroidism was 
partially due to a myosin isozyme shift from V3 to 
V1
22）. On the other hand, Goto Y. et al. reported 
that 14 daily l-thyroxine administration for rabbits 
caused cardiac hypertrophy, but the heart rate and 
Emax were similar for control and hyperthyroid 
hearts23） in agreement with our results obtained 
from mice. Therefore, hyperdynamic state caused 
by hyperthyroidism seems to be considerably 
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due to an increase of heart rate and a decrease 
of arterial resistance. LV contractility of smaller 
animals with higher spontaneous heart rate seems 
to be less affected by hyperthyroidism. Another 
possible reason for the inconsistency of the effects 
of hyperthyroidism on LV contractility between 
studies is the dose and duration of thyroid hormone 
administration.
   E-C coupling Vo 2 is primarily due to energy 
consumption for Ca2+ handling because Na+ 
handl ing  energy  i s  negl ig ib ly  smal l 11）.  In 
cardiomyocytes, there are two major Ca2+ handling 
routes that have different molecular Ca2+ ATPase 
stoichiometries. One is the internal (intracellular) 
Ca2+ route, including ryanodine receptors that are 
responsible for the release of Ca2+ from SR and 
SERCA that sequesters Ca2+ from cytosol into SR. 
The other is the external (transsarcolmmal) Ca2+ 
route, including a L-type Ca2+ channel for the influx 
of Ca2+ and an Na+/ Ca2+ exchanger for the efflux of 
Ca2+. In the internal Ca2+ route, SERCA has a 2Ca2+ 
1 ATP stoichiometry of Ca2+ handling via SR24）. On 
the other hand, the Na+/ Ca2+ exchanger has a 3Ca2+ 
1Na+ stoichiometry, and the Na+/ K+ pump has a 
3Na+ 1ATP stoichiometry. Therefore, the overall 
Ca2+ ATPase stoichiometry in the external Ca2+ 
route eventually becomes 1Ca2+ 1ATP25）. Due to this 
twofold difference in Ca2+ ATPase stoichiometry, the 
shift of Ca2+ handling from the internal route to the 
external route results in the increased O2 consuming 
for Ca2+ handling. In the present study, a decrease 
in NCX and an increase in SERCA expression 
were observed in hyperthyroidism, indicating 
that a greater amount of total cytosolic Ca2+ was 
handled more economically. This is another possible 
mechanism of the O2 saving effect for E-C coupling 
in hyperthyroidism. 
   In the isolated cardiomyocyte experiments, cell 
shortening in T3-short was similar to that in the 
control, and a significant decrease was observed 
in T3-long. These findings were consistent with 
the results of the LV global contractility Ees. The 
reason why global and cellular contractility were 
diminished, despite a constancy of peak amplitude 
of the Ca2+ transients, may be explained by futile 
Ca2+ cycling and/or a decrease in the Ca2+ sensitivity 
of myofilaments26，27）. Fluorescent immunostaining 
showed that the localization of NCX to T-tubule 
became unclear in T3-long, indicating that the 
dysfunction of cooperation between T-tubule and 
SR could be another mechanism for the depression 
of LV contractility. As for increased LV relaxation, 
concomitant effects of decreased NCX activity and 
increased SERCA activity resulted in a significant 
shortening of the decay time constant of the Ca2+ 
transient in T3-long. As for the relation between 
NCX and heart failure, many studies reported that 
NCX expression was increased in human heart 
failure and also animal models of cardiac hypertrophy 
and heart failure28，29）. Enhanced NCX expression 
has been considered as a beneficial compensatory 
mechanism for improving LV contractility30）.
Therefore, a decrease of NCX expression caused 
by hyperthyroidism may be detrimental to a long-
term maintenance of cardiac function in spite of 
acute beneficial effects by O2 saving property for 
Ca2+ handling in response to an acute increase of 
mechanical work caused by a decreased arterial 
resistance and an increased circulating blood 
volume. To assess whether decreased expression of 
NCX could be responsible for the progression of 
heart failure in hyperthyroidism, cardiac specific 
and drug-inducible overexpression of NCX on 
hyperthyroid mice will be warranted.
   Additionally, we performed qPCR for the thyroid 
hormone receptor α, which has been reported to 
be negatively regulated by the thyroid hormone31）, 
to investigate whether the long-term administration 
of the thyroid hormone affects cardiomyocytes. 
Administration of T3 halved mRNA expression of 
thyroid hormone receptor α both in T3-short and 
T3-long.
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   The limitations of the present study are discussed. 
First, it has been reported that the LV Ees in rats was 
not always linear but convex superior at a high LV 
pressure range32）. However, we obtained the value 
of Ees at a lower LV pressure range by performing 
IVCO; linear regression for Ees showed good 
correlation and therefore the Ees values are reliable 
as a contractility index. Second, we could not show 
the hyperkinetic state caused by the thyroid hormone 
in LV mechanics experiments. One possible reason 
is the heart rate, which was kept constant during 
the measurement. Hyperthyroidism increases the 
heart rate, resulting in higher LV contractility 
with an increase in the peak amplitude of the Ca2+ 
transients in a conscious state. Third, we kept the 
heart rate 500 ± 20 beats/min during LV mechanics 
experiments by controlling the concentration of 
sevoflurane as described in materials and methods 
to avoid the effects of heart rate on LV contractility. 
However,  there is  a possibil i ty that  higher 
concentration of sevoflurane was needed to control 
the heart rate in T3-treated groups resulting in a 
greater suppression of LV contractility compared to 
control. To assess this possible bias, we performed 
a chronic recording of electrocardiography on an 
unrestrained, conscious mouse. The values of the 
heart rate in control, T3-short, and T3-long were 
648, 698, and 719 beats/min, respectively. Increases 
in the heart rate in T3-treated groups seems to be 
relatively small (～10%) compared with larger 
animals that show lower spontaneous heart rate22）. 
Therefore, although the difference of necessary 
concentrations of sevoflurane among the groups 
to keep the similar heart rate can be a reason why 
LV contractility in T3-short was similar to that 
in control in contrast to earlier studies that show 
higher LV contractility in acute hyperthyroidism22）, 
this bias can be considered relatively small in mice 
model. 
   In conclusion, we succeeded in evaluating LV 
contractility in hyperthyroid mice by using an 
Ees index that is practically load-independent. T3 
administration shifted the Ca2+ route to the O2-saving 
energetics in the E-C coupling by a decrease in 
NCX and an increase in SERCA expression. Despite 
these energy-saving changes, LV contractility was 
diminished with long-term T3 administration, 
showing a constancy of the peak amplitude of the 
Ca2+ transients and a decrease in NCX activity. 
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